The campaign against the most valuable medical technologies ever invented is based on junk science.

A speculative study about the relationship between the measles, mumps, and rubella vaccine and autism in the prestigious British medical journal The Lancet was retracted today for having numerous flaws and insufficient data within it.

U.S. regulations are too cautious. Europe has adopted a more sensible approach.

We have made progress in pandemic preparedness, but we have a long way to go in ensuring a vibrant and responsive vaccine sector.

At this AEI event, panelists will comment on the CDC's future with vaccines, drawing from experiences in public health, policy, and industry.

Anyone who thinks the vaccine case now before the Supreme Court is merely a matter of giving injured plaintiffs their day in court has misconceived the stakes for those who reap the benefits of vaccines.

The current flu vaccine shortage underscores a much greater problem: vaccine development in the U.S. is stagnant, and many producers have exited the market altogether. While some public health officials believe the solution lies in increased government control of development and production, industry officials point to government control—in the form...

Legislators should adopt policies that encourage companies to make vaccines more quickly and less expensively.